We focused on the annexin A1 (ANXA1) and rho-associated protein kinase-1 (ROCK1) genes, because their expression was upregulated in HD blood and was sensitive to pharmacological treatment [25], [26]. The gene discussed is ANXA1; the disease is Huntington disease.